April has seen a slew of executive hires, promotions and layoffs across the healthcare industry. For instance, Aledade, Humana and Zimmer Biomet named new executives. There were also layoffs at organizations including Baylor Scott & White Health Plan, Novo Nordisk and UnityPoint Health.

The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity News.

Tennessee lawmakers recently passed a bill banning PBMs from owning pharmacies in the state, though like a similar Arkansas law, it is expected to face legal challenges if enacted.

The post Will Tennessee’s PBM Bill Face the Same Fate as Arkansas’ Law? appeared first on MedCity News.

In this episode, we’re joined by Meghan Doyle, CEO of Partum Health. We discuss the company’s new partnership that offers 24/7 access to doula support at University of Chicago Medicine Family Birth Center – Hyde Park.

The post MedCity FemFwd: Inside Partum Health’s Partnership with UChicago Medicine appeared first on MedCity News.

Avalyn Pharma found strong investor interest in its inhalable drugs in development for two types of pulmonary fibrosis, enabling the company to upsize its IPO. Data from two mid-stage studies are expected in 2027.

The post Avalyn Pharma Takes a Breath to Raise $300M in IPO Cash for Lung Drug Trials appeared first on MedCity News.

Despite genuine efforts across the industry to reduce protocol complexity, the trend line hasn’t budged. The reasons are partly scientific and operational. And they’re also deeply human.

The post Why Protocol Complexity Keeps Increasing – and How to Fix It appeared first on MedCity News.

Technology alone is not the answer to the capacity crisis facing healthcare. But when thoughtfully integrated into care delivery operations, digital tools can help healthcare organizations rebalance workloads and stabilize patient access.

The post Repurpose, Don’t Replace: Three Ways Digital Agents Are Improving Phone Access appeared first on MedCity News.

Benefits leaders have become increasingly sophisticated in managing pharmacy spend and high-cost claims. MSK deserves similar strategic attention – not only because it is expensive, but because it is largely preventable.

The post Musculoskeletal Disorders Are Draining Employer Health Budgets — The Workplace Itself May Be the Cause appeared first on MedCity News.

The first major update to HIPAA in more than a decade will eliminate the distinction between “required” and “addressable” safeguards, making key cybersecurity and physical security measures mandatory for all healthcare providers. This shift will expose gaps in hospitals’ fragmented security systems, though, according to Kumar Sokka, CEO of cybersecurity platform Acre Security.

The post Why Some Hospitals Won’t Be Able to Comply With Upcoming HIPAA Updates appeared first on MedCity News.

Health tech companies made several major funding announcements in April. Here is a list of some of the biggest funding rounds.

The post 4 Notable Health Tech Funding Announcements in April appeared first on MedCity News.

KalVista Pharmaceuticals brings to Chiesi Group the product Ekterly, the first FDA-approved oral drug for acute treatment of swelling attacks from the rare disease hereditary angioedema. Ekterly’s tablet formulation offers a dosing edge compared to injectable HAE medications.

The post Chiesi Group Grows Again in Rare Disease With $1.9B KalVista Acquisition appeared first on MedCity News.

Layoffs tied to AI adoption will not be uniform; they will vary by sector, job function, and regulatory exposure. Nowhere is this more complex than in healthcare, where legal constraints, patient safety obligations, and labor dynamics intersect with rapid technological change.

The post AI-Driven Layoffs In Healthcare: Navigating Legal Risks and Operational Challenges appeared first on MedCity News.

Financial assistance is moving from discretionary policy to regulated infrastructure. For health systems, that shift has significant operational and financial implications.

The post Financial Assistance Reform Is Reshaping Revenue Cycle Strategy appeared first on MedCity News.

In today’s cash- and staffing-strapped, high-stakes healthcare environment, COEs are an operational necessity. The most successful organizations treat them as long-term strategic investments, or engines for scalable, sustainable transformation.

The post Beyond Support Teams: The Strategic Role of Centers of Excellence in Healthcare appeared first on MedCity News.

Medtronic suffered a cyberattack on its corporate IT systems. The incident highlights growing cybersecurity risks in the medtech sector, with cybergangs increasingly using phishing and other human-engineering tactics to gain access to data.

The post 6 Things to Know About Medtronic’s Cyberattack appeared first on MedCity News.

Lawmakers introduced the Medicare Advantage Improvement Act of 2026 to tighten prior authorization rules, boost transparency and curb practices that delay care.

The post Bipartisan Bill Seeks to Strengthen Oversight of Medicare Advantage appeared first on MedCity News.

Coultreon Biopharma’s lead drug candidate, acquired from Galapagos, is a small molecule designed to selectively inhibit a novel immunology target called SIK3. The Series A financing will support Phase 2 clinical trials in psoriasis and ulcerative colitis.

The post Immunology-Focused Coultreon Adds $125M for Pills That Pack the Punch of Injectable Biologics appeared first on MedCity News.

As biologics modalities diversify and processes grow complex, the success of tech transfer depends on integrated execution rather than each procedural completion.

The post Executing Biologics Technology Transfer through Integrated Operating Models appeared first on MedCity News.

Many health plans are discovering that even after digitizing medical policies and implementing FHIR APIs, prior authorization turnaround times remain slow and provider frustration remains high. The reason is straightforward: digitization alone does not make medical‑necessity determinations executable by automated systems at scale.

The post Digitizing Medical Policy Alone Will Not Automate Prior Authorization at Scale appeared first on MedCity News.

This is forcing brokers to rethink how they serve clients and how their businesses continue to grow without sacrificing service.

The post As Health Costs Hit Record Highs, Brokers Face a Structural Test appeared first on MedCity News.

Nvidia and Hoppr are betting that healthcare AI will scale not through standalone applications, but through a new infrastructure layer that lets providers develop and deploy their own imaging models.

The post Why Healthcare AI Still Can’t Scale — and How Nvidia & Hoppr Are Trying to Fix It appeared first on MedCity News.

Ed Park is sincere and passionate about his calling as the CEO of Devoted Health, which provides Medicare Advantage plans to seniors in 29 states. But it remains to be seen if he can do more or the same with less.

The post CEO of For-Profit MA Plan Tells CMS “Pay Us Less” appeared first on MedCity News.

Timely by DrFirst launched a tool to streamline prior authorizations and improve access to specialty medications.

The post Timely by DrFirst Aims to Lower Barriers to Specialty Meds appeared first on MedCity News.

Intellia Therapeutics’ lonvo-z uses CRISPR to inactivate a gene in the liver to reduce levels of a protein key to the swelling attacks from the rare disease hereditary angioedema. Intellia has filed a regulatory submission for this genetic medicine, which could become the first in vivo gene-editing therapy to land FDA approval.

The post Intellia’s Data Reveal Tees Up FDA Filing for CRISPR-Based In Vivo Gene-Editing Med appeared first on MedCity News.

In dental practices, where reimbursement cycles are tighter and administrative inefficiencies are immediately visible, AI is already being evaluated not for novelty, but for operational impact.

The post What Dentistry Is Teaching Healthcare About Operational AI appeared first on MedCity News.

The evolution of patient-matched medical devices represents more than just innovation in manufacturing and design. It marks a shift in clinical philosophy. Instead of shaping patients to fit implants, clinicians and device developers are harnessing technology to shape treatments around the individual.

The post How Recent Changes in ‘Patient-Matched’ Technology Are Reshaping the Future of Surgical Care appeared first on MedCity News.

The phenomenon of taking five or more medicines at the same time has become so common that it now has its own term – polypharmacy – and there is no doubt that it increases the risk of dizziness, confusion, and loss of balance.

The post Too Many Prescriptions, Too Many Fatal Falls appeared first on MedCity News.

As patients take to social media, in all its ungated glory and promotion of misinformation, how can they be certain that what they are getting is accurate? What voices can they trust?

The post Patients are Turning to HCP Influencers in the Age of AI and Misinformation appeared first on MedCity News.

Midstream Health is taking a bit of a different approach to healthcare AI by focusing on reducing hospitals’ costs rather than boosting their revenue. The startup uses AI to identify savings opportunities across fragmented spending data, which helps health systems like Mount Sinai and CommonSpirit quickly improve their purchasing decisions.

The post Why Some Hospitals Are Betting on Midstream Health to Help Eliminate Waste appeared first on MedCity News.

The World Health Organization has prequalified Coartem Baby, the first and only antimalarial for babies. Novartis developed this combination drug in partnership with Medicines for Malaria Venture.

The post Novartis Antimalarial Clears Key WHO Review to Get the Combo Drug to Babies appeared first on MedCity News.

The American Medical Association is urging Congress to add safeguards for AI mental health chatbots amid safety concerns, while noting their potential to expand access.

The post AMA Calls on Congress to Improve Safeguards for AI Mental Health Chatbots appeared first on MedCity News.